drugset / Trial / NCT01127048

Prospan® Hustenzäpfchen - Investigation on Efficacy and Tolerability in Children

NCT01127048 ↗

Phase 3 Unknown 1400 enrolled Engelhard Arzneimittel GmbH & Co.KG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aims of this study are * Demonstrating superior efficacy of Prospan® Hustenzäpfchen compared to Placebo in children suffering from acute bronchitis accompanied by coughing * Characterisation of safety and tolerability of Prospan® Hustenzäpfchen in comparison with placebo.

Timeline

Start
2008-10
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject ivy leaves dry extract Unknown — —

Indications